# Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke

Study · id `cardio:ct-nct02762552` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02762552](<https://clinicaltrials.gov/study/NCT02762552>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02762552

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 244 participants.

## Technical summary

Registry record NCT02762552. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-09-14 (actual); primary completion 2017-05-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 244 participants (enrolled count; ClinicalTrials.gov record NCT02762552, source copy `cardio:ctgov-nct02762552-2026-06-01`, retrieved 2026-10-26)
- Started: 2015-09-14 (actual) (ClinicalTrials.gov record NCT02762552, source copy `cardio:ctgov-nct02762552-2026-06-01`, retrieved 2026-10-26)
- Primary completion: 2017-05-11 (actual) (ClinicalTrials.gov record NCT02762552, source copy `cardio:ctgov-nct02762552-2026-06-01`, retrieved 2026-10-26)
- Completion: 2018-08-14 (actual) (ClinicalTrials.gov record NCT02762552, source copy `cardio:ctgov-nct02762552-2026-06-01`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02762552, source copy `cardio:ctgov-nct02762552-2026-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02762552-2026-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke
- Acronym: HOLISTER
- Condition: Stroke
- Intervention (Device): Transcranial-holter monitoring
- Lead sponsor: University Hospital, Bordeaux
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital, Bordeaux (`cardio:org-university-hospital-bordeaux`)

## Provenance

Content hash: 012ace6a55378b49fe80617c02ef5d91d898233f56d24da6df7f9dacf61b0cec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
